About this trial
Commercially pure (CP) titanium is the gold standard to produce dental implants because it has a huge volume of scientific publications over a period of more than 50 years, it is cheap and simple to produce (i.e., making dental implants economically "affordable") and comes in numerous specitic designs of screws tor various indications. That is why more than 95% of the implant market 5 dominated by titanlum.
However, there is an innovation trend to manufacture implants from more inert and biocompatible materials. Ceramic implants represent a valuable alternative for expanding the patient base of clinicians, especially in cases with challenging aesthetic demand. Furthermore, there has been a significant increase in the number of patients requesting metal-free dentistry or bio-holistic implant treatments.
In the past, ceramics were often branded as "inferior" quality due to its reputation as being brittle but the growing volume of scientific publications specifically an zirconia are demonstrating that lt is comparable in fracture-strength with titanium implants. There is a clear market niche for zirconia implants, especially in cases of:
* Aesthetic reconstructions in the anterior region, especially in patients with a thin gingival biotype * Gingival recessions where a white colored implant is a great advantage * For patients with a titanium intolerance/sensitivity * For patients who prefer a bio-holistic/metal-free dental approach.
Today, clinicians are asking tor long-term clinical results of zirconia as a dental implant material. Therefore, Z-Systems AG is conducting this zirconia dental implant registry. A registry design was chosen because it will capture long-term benefits/risks from clinical routine without patient selection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patient (≥ 18 years) was or will be implanted with up to 5 implants of the Z-Systems Z5m product group
Patient has signed Informed Consent.
Disqualifiers
None
Trial population
The patient population is anyone needing to have their missing teeth replaced.
Trial design
Cohort
Other
Treatments tested in this trial
Z5m Dental Implants
DeviceThis is an observational study, collecting data on the use of Z5m Dental Implants.
Treatment groups
Trial outcomes
Primary outcomes
Absence of persistent subjective complaints
Absence of persistent subjective complaints such as pain, foreign body sensation and/or dysesthesia
Absence of peri-implant infection
Absence of peri-implant infection with suppuration
Absence of mobility
Absence of mobility of dental implant
Secondary outcomes
Frequency of occurrence of device related Adverse Device Events (ADEs) and Serious Adverse Device Events (SADEs)
Secondary Safety Outcome is frequency of occurrence of device related Adverse Device Events (ADEs), Serious Device Events (SADEs). Measured by asking patient if any adverse events occured since last follow-up.
Exploratory outcomes - complaints and incidence
Rate of complaints and incidents related to the medical device during the whole registry.
Exploratory outcomes - clinical satisfaction
Clinical satisfaction measured on a Likert scale: 1 to 6, with 1 being "not satisfied at all" to 6 being "highly satisfied.
Exploratory outcomes - patient satisfaction
The patient's assessment of function and aesthetics is recorded by his/her assessment of function, aesthetic appearance, implants, speech and self-confidence. The parameters are assessed by rating the degree of satisfaction on a 100 mm Visual Analogue Scale (VAS).